Skip to content

Gross Profit at other companies

Pfizer logo
PfizerPFE
$10.9B+0.3%
Amgen logo
AmgenAMGN
$5.87B+13.4%
Organon logo
OrganonOGN
$783M-6.9%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$193.47M+61.3%
LQD
Liquidia CorporationLQDA
$1.6M+6.5%
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.28B+57.5%
Enterprise value$3.36B+57.0%
P/S7.9×-1.9×

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s gross profit?
Arcutis Biotherapeutics, Inc. (ARQT) reported gross profit of $95.61M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s gross profit changed year-over-year?
Arcutis Biotherapeutics, Inc.'s gross profit increased by 67.7% year-over-year, from $57.02M to $95.61M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.